Epidemiology and Prognostic Analysis of Chinese Cancer Patients With Cancer-related Fatigue
ConditionCancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorFudan University
About this trial
This investigator-initiated study aims to evaluate the incidence and severity of cancer-related fatigue (CRF) in patients with malignant tumors, to analyze the influencing factors of CRF, and to explore its impact on anti-tumor treatment and prognosis.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Male or female, aged 18 years or older.
Able to understand the purpose of this survey study, willing to participate, and able to sign an informed consent form.
Malignant tumor confirmed histologically or cytologically.
Disqualifiers
Pregnant or breastfeeding women.
Patients with acute or chronic infections, or those with other serious medical conditions that, in the investigator's judgment, make them unsuitable for this study.
Patients with two or more concurrent malignant tumors (excluding the following: cured basal cell carcinoma of the skin, carcinoma in situ of the cervix, and papillary thyroid carcinoma).
Patients with psychiatric illness or mental disorders, poor compliance, or who are unable to cooperate and report treatment responses.
Trial population
Patients with malignant tumors in various tumor types and multiple treatment scenarios.
Trial design
Design model
Cohort
Time perspective
Cross-sectional
Treatments tested in this trial
No Interventions
Other interventionNo Interventions
Treatment groups
1,000,000 Participants
are divided into 1 treatment groupGroup A: Patients with malignant tumors1 intervention
Trial outcomes
Primary outcomes
1
The incidence of cancer-related fatigue (CRF) in tumor patients.
The incidence of cancer-related fatigue (CRF) in tumor patients.
Time frame
BaselineSecondary outcomes
1
The severity grading of cancer-related fatigue (CRF) in tumor patients across different tumor types and multiple treatment settings.
The severity grading of cancer-related fatigue (CRF) in tumor patients across different tumor types and multiple treatment settings.
Time frame
Baseline2
The correlation between treatment regimen and the incidence of cancer-related fatigue (CRF).
Time frame
Baseline3
The incidence of anti-tumor treatment delays, dose reductions, or regimen modifications due to cancer-related fatigue (CRF).
Time frame
Baseline4
Progression-free survival (PFS) and overall survival (OS) in patients with different grades of cancer-related fatigue (CRF) undergoing anti-tumor therapy.
Time frame
BaselineSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov